Brunhild Pharmaceuticals Private Limited
About Brunhild Pharmaceuticals Private Limited
Data last updated:
Brunhild Pharmaceuticals Private Limited is a private limited company based in Naigaon, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2010PTC198897. Its GSTIN is 27AADCC8476A1ZP (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Coguire Web Venture Private Limited. It is led by directors Ganesan Subramanian Iyer and Rajesh Felix Dsilva.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at L4/G3 Royal Complex Opp. Don Bosco School Near Laxmi Pink City Juichandra, Naigaon, Maharashtra, India – 401102.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.43 Cr, a growth of 57% compared to the previous year. For the same year it recorded a net profit of ₹9.54 Lakh (net margin 6.7%) and EBITDA of ₹9.77 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 301% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Brunhild Pharmaceuticals has one previous CIN (Corporate Identification Number): U74990MH2010PTC198897. The current CIN is U74900MH2010PTC198897, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900MH2010PTC198897 | Current |
| U74990MH2010PTC198897 | Previous |
Contact details
Brunhild Pharmaceuticals Private Limited's registered office is in Naigaon, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressL4/G3 Royal Complex Opp. Don Bosco School Near Laxmi Pink City Juichandra, Naigaon, Maharashtra, India – 401102
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Brunhild Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Brunhild Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Brunhild Pharmaceuticals Private Limited, buy the company report.
Financials of Brunhild Pharmaceuticals Private Limited
FY 2024 filings availableBrunhild Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (up 57% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 301% over five years, including 57% growth in the latest year. EBITDA rose 258% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brunhild Pharmaceuticals Private Limited, buy the company report.
Board of directors of Brunhild Pharmaceuticals Private Limited
Brunhild Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganesan Subramanian Iyer Also directs: Cygnus Health Care Specialities Private Limited | Director | 14 Jan 2010 | 16 Years 9 Months | Current |
| Rajesh Felix Dsilva | Director | 14 Jan 2010 | 16 Years 9 Months | Current |
Auditor
Brunhild Pharmaceuticals Private Limited is audited by Z. J. Arsiwala & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Z. J. Arsiwala & Associates | FY 2023 | 044184 |
Shareholding
The shareholding of Brunhild Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brunhild Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brunhild Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brunhild Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Brunhild Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCC8476A1ZP | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Brunhild Pharmaceuticals Private Limited, buy the company report.
Recent activity
Brunhild Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Ganesan Subramanian Iyer was appointed as Director on 14 Jan 2010.
Frequently asked questions
Brunhild Pharmaceuticals is an active private limited company based in Naigaon, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2010 (16+ years old) and is registered under CIN U74900MH2010PTC198897.
Brunhild Pharmaceuticals has 2 current directors:
- Ganesan Subramanian Iyer - Director
- Rajesh Felix Dsilva - Director
The latest financial statements of Brunhild Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Brunhild Pharmaceuticals is 27AADCC8476A1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Brunhild Pharmaceuticals is U74900MH2010PTC198897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brunhild Pharmaceuticals was incorporated on 14 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Ganesan Subramanian Iyer was appointed as Director on 14 Jan 2010. Rajesh Felix Dsilva was appointed as Director on 14 Jan 2010.
The registered office of Brunhild Pharmaceuticals is at L4G3 Royal Complex Opp. Don Bosco School Near Laxmi Pink City Juichandra, Naigaon, Maharashtra, India – 401102.
Brunhild Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Brunhild Pharmaceuticals is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
